If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,904.00    -108.00 (-3.59%)
Bid:
2,902.00
Ask:
2,906.00
Spread: 4.00 (0.138%)
Market Cap: £1.60b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Disposal

18 Nov 2016 07:00

RNS Number : 5211P
Oxford Instruments PLC
18 November 2016
Β 

Release date: 18 November 2016

Oxford Instruments plc

Disposal of Oxford Instruments Superconducting Wire LLC ("OST")

Β 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the disposal of Oxford Instruments Superconducting Wire LLC ("OST") to Bruker Energy and Supercon Technologies Inc ("BEST"), a subsidiary of Bruker Corporation, for a consideration of $17.5 million, payable in cash. In the transaction, BEST has acquired the entire share capital of OST from Oxford Instruments.

Β 

OST supplies world-leading superconducting wire for use in MRI scanners and other medical and scientific applications; it is located in Carteret, New Jersey, USA. The business was previously part of Oxford Instruments' Industrial Products division.

Β 

In the year ended 31 March 2016, OST had revenues of Β£42.4 million and achieved an operating profit of Β£3.4 million. In the six months to 30 September 2016, OST had revenues of Β£19.1 million and achieved an operating profit of Β£1.1 million. The gross assets of OST at 31 March 2016 were Β£19.0 million.

Oxford Instruments has previously reported challenges within the superconducting wire markets due primarily to pricing pressures exerted by the MRI system manufacturers and reduced demand for wire from OEM customers. The disposal represents a further step in the Group's strategy of actively managing its portfolio.

Ian Barkshire, Chief Executive of Oxford Instruments said "After a comprehensive review of our portfolio, the Board has determined that our Superconducting Wire business is no longer core to the Group's long-term strategic vision. The divestment will allow increased focus across the Group on our chosen market segments and the cash proceeds will enable us to reduce our net debt, in line with our strategy to deliver enhanced shareholder value.

"OST is a high quality business and we believe that as part of BEST, it will benefit from the realisation of synergies and the scale of BEST's expertise in low-temperature superconductors. This will ensure that the business continues to provide customers with the highest quality products and fosters the exceptional skills of its talented workforce."

Β 

Enquiries:

Β 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

Β 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Jamie Ricketts

Β 

Β 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to EditorsΒ Β 

Β 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.Β 

Β 

The first technology business to be spun out fromΒ OxfordΒ University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is toΒ be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

Β 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; NuclearΒ Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Β 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. ItsΒ products, expertise, and ideas address global issues such as energy, environment, security and health.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DISDXBDBDXBBGLR
Date   Source Headline
16th Apr 20257:00 amRNSTrading Update
15th Apr 20251:30 pmPRNHolding(s) in Company
14th Apr 20253:33 pmPRNDirector/PDMR Shareholding
10th Apr 20257:00 amRNSHolding(s) in Company
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 202512:35 pmPRNHolding(s) in Company
24th Mar 20252:35 pmPRNHolding(s) in Company
7th Mar 20259:00 amPRNHolding(s) in Company
6th Mar 20258:30 amPRNHolding(s) in Company
5th Mar 202511:37 amPRNHolding(s) in Company
5th Mar 202510:40 amPRNDirector/PDMR Shareholding
3rd Mar 202510:59 amPRNTotal Voting Rights
17th Feb 20258:52 amPRNDirectorate Change
10th Feb 20253:26 pmPRNDirector/PDMR Shareholding
3rd Feb 20251:30 pmPRNTotal Voting Rights
13th Jan 202511:09 amPRNDirector/PDMR Shareholding
9th Jan 20257:00 amRNSChief Financial Officer succession
7th Jan 20254:48 pmPRNDirector Declaration
3rd Jan 202511:39 amPRNBlocklisting - Interim Review
2nd Jan 202511:38 amPRNTotal Voting Rights
13th Dec 202412:15 pmRNSHolding(s) in Company
12th Dec 20243:41 pmRNSDirector/PDMR Shareholding
2nd Dec 202411:00 amPRNTotal Voting Rights
12th Nov 202412:30 pmPRNDirector/PDMR Shareholding
12th Nov 20247:00 amRNSHalf-Year Results
8th Nov 202411:54 amPRNHolding(s) in Company
23rd Oct 20242:30 pmPRNHolding(s) in Company
16th Oct 20247:00 amRNSHalf Year Trading Update
14th Oct 20248:54 amPRNDirector/PDMR Shareholding
1st Oct 202411:31 amPRNTotal Voting Rights
11th Sep 20243:48 pmPRNDirector/PDMR Shareholding
2nd Sep 20248:39 amPRNTotal Voting Rights
14th Aug 20249:09 amPRNDirector/PDMR Shareholding
12th Aug 20244:37 pmPRNDirector/PDMR Shareholding
9th Aug 20241:15 pmPRNDirector/PDMR Shareholding
1st Aug 202410:57 amPRNTotal Voting Rights
26th Jul 20249:59 amPRNAnnual General Meeting 2024 Results
25th Jul 20249:31 amPRNDirector/PDMR Shareholding
24th Jul 20249:00 amPRNDirector Declaration
23rd Jul 20244:00 pmPRNDirector/PDMR Shareholding
18th Jul 20244:32 pmPRNHolding(s) in Company
18th Jul 20244:29 pmPRNHolding(s) in Company
18th Jul 20248:00 amPRNBlock Listing Application
12th Jul 20241:04 pmPRNHolding(s) in Company
12th Jul 202410:05 amPRNDirector/PDMR Shareholding
2nd Jul 20242:11 pmPRNBlocklisting - Interim Review
1st Jul 202412:21 pmPRNTotal Voting Rights
1st Jul 20249:14 amRNSCompletion of acquisition of FemtoTools AG
25th Jun 202412:51 pmPRNHolding(s) in Company
25th Jun 202410:40 amPRNPublication of Annual Report 2024 and Notice of Annual General Meeting 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.